A Follow-up Study for Causes of Cancer in Black Women
09/01/2022 - 08/31/2027 (Multi-PI)
PI: Kimberly Bertrand, ScD
NIH/National Cancer Institute
5U01CA164974-13

Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts
09/20/2021 - 08/31/2026 (Subcontract PI)
University of California, Irvine NIH NCI
5R01CA260615-02

Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities
06/01/2021 - 05/31/2026 (PI)
NIH/National Cancer Institute
5R01CA249982-03

Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities
02/05/2021 - 01/31/2026 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NCI
5U01CA250476-02

Black Women's Health Study samples for a multi-ancestry genome-wide association study of lymphoid malignancies
08/30/2023 - 08/29/2024 (PI)
NIH/National Cancer Institute
75N91023P00774

A prediction model to simultaneously estimate personal risk of breast cancer and death from other causes in women aged 55 and older
08/01/2020 - 04/30/2024 (Subcontract PI)
Beth Israel Deaconess Medical Center, Inc NIH NCI
5R01CA242747-03

Conducting a National Death Index search among three generations of DES-exposed and unexposed study participants
05/17/2022 - 11/30/2023 (Subcontract PI)
Westat, Inc. NIH NCI
75N91021C00012

Mammographic density and breast cancer risk in African American women
06/16/2017 - 02/28/2023 (PI)
NIH/National Cancer Institute
5R01CA214542-04

RiRisk factors for molecular subtypes of NHL - a prospective evaluation
08/01/2016 - 07/31/2022 (Subcontract PI)
Beckman Research Institute of the City of Hope NIH NCI
5R01CA202712-05

1. Habeshian TS, Peeri NC, De Vivo I, Schouten LJ, Shu XO, Cote ML, Bertrand KA, Chen Y, Clarke MA, Clendenen TV, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, Gallagher G, Gierach GL, Goodman MT, Jordan SJ, La Vecchia C, Lacey JV, Levi F, Liao LM, Lipworth L, Lu L, Matías-Guiu X, Moysich KB, Mutter GL, Na R, Naduparambil J, Negri E, O'Connell K, O'Mara TA, Onieva Hernández I, Palmer JR, Parazzini F, Patel AV, Penney KL, Prizment AE, Ricceri F, Risch HA, Sacerdote C, Sandin S, Stolzenberg-Solomon RZ, van den Brandt PA, Webb PM, Wentzensen N, Wijayabahu AT, Wilkens LR, Xu W, Yu H, Zeleniuch-Jacquotte A, Zheng W, Du M, Setiawan VW. Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiol Biomarkers Prev. 2024 Mar 26.View Related Profiles.

   Palmer, Julie
   Bertrand, Kimberly
   

   PMID: 38530242
2. Troisi R, Bertrand K, Hatch EE, Strohsnitter WC, Aagaard K, Robboy SJ, Gierach G, Titus L. An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract. Obstet Gynecol. 2024 Apr 01; 143(4):603-606.View Related Profiles.

   Hatch, Elizabeth
   Bertrand, Kimberly
   

   PMID: 38422500
3. Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, Chen Y, DeHart JC, Dossus L, Eliassen AH, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson SE, Heath A, Jones ME, Joshu CE, Kaaks R, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Masala G, Mellemkjaer L, Milne RL, O'Brien KM, Palmer JR, Riboli E, Rohan TE, Shrubsole MJ, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen RC, Weiderpass E, Willett WC, Yuan JM, Zeleniuch-Jacquotte A, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ, Weinberg CR. BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 2024 Apr; 89:102545.View Related Profiles.

   Palmer, Julie
   Bertrand, Kimberly
   

   PMID: 38377945
4. Kataria Y, Niharika Pillalamarri B, Zirpoli G, Szalat R, Palmer JR, Bertrand KA. Body size and risk of multiple myeloma in the Black Women's Health Study. Br J Cancer. 2024 Mar; 130(5):830-835.View Related Profiles.

   Zirpoli, Gary
   Palmer, Julie
   Bertrand, Kimberly
   Szalat, Raphael
   Kataria, Yachana
   

   PMID: 38212484; PMCID: PMC10912597; DOI: 10.1038/s41416-023-02571-w;
5. Wolfson EA, Schonberg MA, Eliassen AH, Bertrand KA, Shvetsov YB, Rosner BA, Palmer JR, LaCroix AZ, Chlebowski RT, Nelson RA, Ngo LH. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older. J Natl Cancer Inst. 2024 Jan 10; 116(1):81-96.View Related Profiles.

   Palmer, Julie
   Bertrand, Kimberly
   

   PMID: 37676833; PMCID: PMC10777669; DOI: 10.1093/jnci/djad188;
6. Bertrand KA, Szalat R. Deciphering racial disparities in multiple myeloma outcomes. Blood Adv. 2024 Jan 09; 8(1):234-235.View Related Profiles.

   Bertrand, Kimberly
   Szalat, Raphael
   

   PMID: 38194241; PMCID: PMC10918417; DOI: 10.1182/bloodadvances.2023011457;
7. Zirpoli GR, Pfeiffer RM, Bertrand KA, Huo D, Lunetta KL, Palmer JR. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women. Breast Cancer Res. 2024 Jan 02; 26(1):2.View Related Profiles.

   Zirpoli, Gary
   Palmer, Julie
   Lunetta, Kathryn
   Bertrand, Kimberly
   

   PMID: 38167144; PMCID: PMC10763003; DOI: 10.1186/s13058-023-01748-8;
8. Timmins IR, Jones ME, O'Brien KM, Adami HO, Aune D, Baglietto L, Bertrand KA, Brantley KD, Chen Y, Clague DeHart J, Clendenen TV, Dossus L, Eliassen AH, Fletcher O, Fournier A, Håkansson N, Hankinson SE, Houlston RS, Joshu CE, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Lynch BM, May AM, Mellemkjær L, Milne RL, Palmer JR, Ricceri F, Rohan TE, Ruddy KJ, Sánchez MJ, Shu XO, Smith-Byrne K, Steindorf K, Sund M, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zheng W, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 2024 Mar 10; 42(8):927-939.View Related Profiles.

   Palmer, Julie
   Bertrand, Kimberly
   

   PMID: 38079601
9. Tehranifar P, Bertrand KA. Enhancing Mammography and Empowering Solutions for Breast Cancer Disparities. Cancer Epidemiol Biomarkers Prev. 2023 Nov 01; 32(11):1479-1481. PMID: 37908191
10. Bertrand KA, Delp L, Coogan PF, Cozier YC, Lenzy YM, Rosenberg L, Palmer JR. Hair relaxer use and risk of uterine cancer in the Black Women's Health Study. Environ Res. 2023 Dec 15; 239(Pt 1):117228.View Related Profiles.

    Palmer, Julie
    Bertrand, Kimberly
    Coogan, Patricia
    Cozier, Yvette
    

    PMID: 37821068; PMCID: PMC10842360; DOI: 10.1016/j.envres.2023.117228;

Showing 10 of 149 results. Show More

FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late

FDA Move to Ban Hair Relaxer Chemical Called Too Little, Too Late

FDA move to ban formaldehyde in hair straighteners called too little, too late

---

Can using everyday hair care products be harmful to your health?

'It's long overdue': Local salons react to FDA proposal to ban hair relaxers

Hair Straighteners and Relaxers May Be Harmful to Health. Here’s How to Make Them Better

Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine Cancer

If You're Using Any ​​of These Toxic Hair Products, Stop Now, FDA Warns`

There’s a straight line between natural-hair discrimination and a higher risk of cancer

For nearly 30 years, Boston University has led the largest and longest-running study of Black women’s health, shining a light on tragic disparities and showing women their lives matter

If You're Using Any ​​of These Toxic Hair Products, Stop Now, FDA Warns

FDA considers ban on some Black women's hair products that have caused years of harm

FDA is considering a ban on certain hair-straightening chemicals: It would be a ‘win for public health—especially the health of Black women’

FDA considering a ban on hair-straightening chemicals. Stylists say Black women have moved on

: FDA is thinking about a ban on hair-straightening chemicals. Stylists say Black women have moved on

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers

What Black women should know about hair relaxers and their health

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers

FDA May Ban Formaldehyde in Hair Straightening Products Over Uterine Cancer Risks

Another Study Has Linked Chemical Hair Straighteners to Uterine Cancer

What Black women should know about hair relaxers and their health

FDA plans to propose ban on formaldehyde in hair smoothing, straightening products — here's what to know.

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers

What to Know About the Health Risks of Chemical Hair Straighteners

FDA proposes ban on hair relaxers with formaldehyde

Use of Hair Relaxers Raises Women's Odds for Uterine Cancer

Use of Hair Relaxers Raises Women's Odds for Uterine Cancer

HAIR RELAXERS MAY BOOST BLACK WOMEN’S UTERINE CANCER RISK

Study: Chemical hair relaxers may put Black women at higher risk for uterine cancer

BU Study: Long-Term Use Of Chemical Hair Relaxers Linked To Risk Of Cancer

Yes, some chemicals used in hair products for Black women can lead to breast cancer

Relaxed Hair Has Made a Comeback on Social Media, Reigniting a Debate on the Straight Style

Are hair relaxers causing breast cancer in black women?

Are hair relaxers causing breast cancer in black women? – podcast

Wellness Wednesday: How To Address Racial Disparities In Breast Cancer

25-year-long study of Black women links frequent use of lye-based hair relaxers to a higher risk of breast cancer

25-year-long study of Black Women links frequent use of lye-based hair relaxers to a higher risk of breast cancer

Does Using Hair Relaxers Cause Higher Breast Cancer Risk for Black Women?

Untangling Link Between Hair Relaxers and Breast Cancer Risk in Black Women

Moderate Use of Hair Relaxers Won't Raise Black Women's Cancer Risk: Study

Hair Relaxers Won't Raise Black Women's Cancer Risk